| Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. | |
| | |
MedLine Citation:
|
PMID: 16391641 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Case report: Infectious keratitis after laser-assisted in situ keratomileusis (LASIK) is a rare complication that may be challenging to diagnose and treat. We discuss some of the reasons for difficulties diagnosing postoperative atypical or nontuberculous mycobacterial infection and establishing an effective treatment, with reference to reports of comparative antibacterial activity of the most commonly used antibiotics.Comments: To the best of our knowledge, we are the first to report the use of the fourth-generation fluoroquinolone moxifloxacin in combination therapy for the successful treatment of this condition. |
| | |
Authors:
|
Sao Bing Lee; Karine M Oliver; Yi Ning J Strube; Subhash K Mohan; Allan R Slomovic |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie Volume: 40 ISSN: 0008-4182 ISO Abbreviation: Can. J. Ophthalmol. Publication Date: 2005 Dec |
Date Detail:
|
Created Date: 2006-01-04 Completed Date: 2006-03-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0045312 Medline TA: Can J Ophthalmol Country: Canada |
Other Details:
|
Languages: eng Pagination: 750-3 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology and Vision Science, University of Toronto, Ontario. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Bacterial Agents
/
therapeutic use* Aza Compounds / therapeutic use* Clarithromycin / therapeutic use Corneal Ulcer / drug therapy*, microbiology Drug Therapy, Combination Eye Infections, Bacterial / drug therapy* Female Humans Keratomileusis, Laser In Situ* Microbial Sensitivity Tests Middle Aged Mycobacteria, Atypical / drug effects, isolation & purification Mycobacterium Infections, Atypical / drug therapy* Postoperative Complications* Quinolines / therapeutic use* Surgical Flaps Tobramycin / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Aza Compounds; 0/Quinolines; 0/moxifloxacin; 32986-56-4/Tobramycin; 81103-11-9/Clarithromycin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Eye injuries due to tractor wheel explosion: report of two cases.
Next Document: Choroidal amelanotic melanoma in a patient with oculocutaneous albinism.